Metabolically, dwarfism protects from hepatic insulin resistance, reduces high-fat diet induced liver steatosis and suppresses de-novo lipogenesis genes including Elovl6, Acly and Fasn [64,122,123], thus indicating reduced lipogenic activity through Srebf1 [108,124–126]. The gene discussed is FASN; the disease is Insulin resistance.